| Bioactivity | Zongertinib is a potent tyrosine kinase inhibitor. Zongertinib can be used as an antineoplastic agent. Zongertinib also has been tested as pHER2 and EGFR inhibitor inhibiting a wide variety of cancers[1][2]. |
| Name | Zongertinib |
| CAS | 2728667-27-2 |
| Formula | C29H29N9O2 |
| Molar Mass | 535.60 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. WHO Drug Informat ion - World Health Organization (WHO). [2]. Wilding Birgit, et al. Synthesis of diazino-pyrimidines as anticancer agents: World Intellectual Property Organization, WO2021213800. 2021-10-28. [3]. WHO Drug Information-World Health Organization (WHO). |
Zongertinib
CAS: 2728667-27-2 F: C29H29N9O2 W: 535.60
Zongertinib is a potent tyrosine kinase inhibitor. Zongertinib can be used as an antineoplastic agent. Zongertinib also
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.